StockMarketWire.com - Cambridge Cognition said it has won a contract, worth approximately £0.5 million, from a new pharmaceutical client to provide cognitive assessments in an at-home clinical trial.

The contract revenue is expected to be recognised in 2021.







At 9:43am: [LON:COG] Cambridge Cognition Holdings share price was 0p at 55.5p



Story provided by StockMarketWire.com